Akebia Therapeutics

+$0.0125 (+3.94%) Today
-$0.0094 (-2.85%) As of 12:00 AM UTC after-hours

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell AKBA and other ETFs, options, and stocks.

About AKBA

Akebia Therapeutics, Inc. is a biopharmaceutical company, which engages in the development and commercialization of therapeutics for patients with kidney diseases. The firm is also involved in the development and commercialization of drugs for the treatment of renal and metabolic disorders.

CEO
John P. Butler
Employees
426
Headquarters
Cambridge, Massachusetts
Founded
2007

AKBA Key Statistics

Market cap
60.57M
Price-Earnings ratio
—
Dividend yield
—
Average volume
9.06M
High today
$0.3399
Low today
$0.312
Open price
$0.3189
Volume
5.37M
52 Week high
$4.33
52 Week low
$0.3001

AKBA Earnings

-$0.60
-$0.40
-$0.20
$0.00
Q3 FY20
Q4 FY20
Q1 FY21
Q2 FY21
Q3 FY21
Q4 FY21
Q1 FY22
Q2 FY22
Estimated
— per share
Actual
Expected Aug 4, After Hours
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure